Dietary Supplement Listing Act of 2026

This bill would require companies whose names appear on dietary supplement labels to list each supplement sold in the United States with the Food and Drug Administration (FDA). Listings would include the product name, ingredients and amounts, label copy, serving information, directions, warnings, allergens, form, and certain health claims. Products already on the market would need to be listed within 18 months of enactment, new products when they are first sold, and label changes within 30 days. The FDA would create a public, searchable online database of most listing information within 2 years, while keeping some business contact details and proprietary blend amounts confidential. Supplements without a required listing would be treated as misbranded, and selling supplements made with help from a person barred under the law would be prohibited.

Full text and official record on Congress.gov

Sponsors

• Richard J. Durbin Democrat sponsor
• 0 cosponsors